Stay updated with breaking news from Nasdaq Gnom. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
James J. Burns & Company LLC increased its position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Free Report) by 8.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,939 shares of the company’s stock after […]
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Free Report) was the recipient of a large decline in short interest in September. As of September 15th, there was short interest totalling 15,500 shares, a decline of 95.9% from the August 31st total of 374,700 shares. Based on an average daily trading volume, of 189,100 […]
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Free Report) saw a large drop in short interest in the month of June. As of June 15th, there was short interest totalling 47,100 shares, a drop of 32.2% from the May 31st total of 69,500 shares. Based on an average trading volume of 78,300 shares, the […]
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Rating) saw a large increase in short interest in May. As of May 31st, there was short interest totalling 69,500 shares, an increase of 100.9% from the May 15th total of 34,600 shares. Based on an average daily trading volume, of 83,800 shares, the days-to-cover ratio […]
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Rating) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $12.43 and traded as high as $12.94. Global X Genomics & Biotechnology ETF shares last traded at $12.87, with a volume of 32,679 shares traded. Global […]